Literature DB >> 7522237

Staining pattern of type IV collagen and prognosis in early stage adenocarcinoma of the lung.

N Watanabe1, I Nakajima, S Abe, S Ogura, H Isobe, Y Kawakami.   

Abstract

AIMS: To examine the prognostic value of basement membrane expression in early stage adenocarcinoma of the lung.
METHODS: Using antibodies to type IV collagen, basement membrane expression at the tumour-stromal border was immunohistochemically analysed in 30 patients with early stage adenocarcinoma of the lung (pstage I and pstage II). Two patterns of staining for type IV collagen were observed: in the first one the staining line was conserved or partially fragmented; in the second the staining line was widely fragmented or absent in more than 10% of the tumour area. The first staining pattern was categorised as continuous and the second as discontinuous.
RESULTS: Of the 24 patients with pstage I adenocarcinoma, 12 (50%) cases showed a continuous pattern. In only one (16.7%) of the six patients with pstage II adenocarcinoma was this pattern evident. Five year survival was greater in pstage I adenocarcinoma (65%) than in pstage II adenocarcinoma (17%), but the difference was not significant. When the analysis was restricted to the 24 patients with pstage I adenocarcinoma, five year survival was better in continuous pattern cases (88%) than in discontinuous pattern cases (20.5%) (p < 0.05). The survival curve of 12 patients with pstage I adenocarcinoma and a discontinuous pattern resembled that of the six patients with pstage II adenocarcinoma.
CONCLUSION: These findings suggest that patients with pstage I adenocarcinoma and a discontinuous pattern have histopathologically unrecognised micrometastasis when they come to surgery. The staining pattern of type IV collagen could help in the prognosis of pstage I adenocarcinoma of the lung after surgery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522237      PMCID: PMC502082          DOI: 10.1136/jcp.47.7.613

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  15 in total

1.  Mitotic index in carcinoma of the lung.

Authors:  R D James; A T Davey
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

Review 2.  Tumor invasion and the extracellular matrix.

Authors:  L A Liotta; C N Rao; S H Barsky
Journal:  Lab Invest       Date:  1983-12       Impact factor: 5.662

3.  Immunohistochemical study of basement membrane antigens in bronchioloalveolar carcinoma.

Authors:  W F Grigioni; G Biagini; S Garbisa; A D'Errico; M Milani; M Mastrorilli; V Vasi; V Villanacci; G Gozzetti; A M Mancini
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

4.  Survival of patients surgically treated for stage I lung cancer.

Authors:  D E Williams; P C Pairolero; C S Davis; P E Bernatz; W S Payne; W F Taylor; M A Uhlenhopp; R S Fontana
Journal:  J Thorac Cardiovasc Surg       Date:  1981-07       Impact factor: 5.209

5.  Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung.

Authors:  E H Lipford; J C Eggleston; K D Lillemoe; D L Sears; G W Moore; R R Baker
Journal:  Am J Surg Pathol       Date:  1984-05       Impact factor: 6.394

6.  The changing histopathology of lung cancer: a review of 1682 cases.

Authors:  R G Vincent; J W Pickren; W W Lane; I Bross; H Takita; L Houten; A C Gutierrez; T Rzepka
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

7.  Carcinoma of the lung: evaluation of histological grade and factors influencing prognosis.

Authors:  C K Chung; R Zaino; J A Stryker; M O'Neill; W E DeMuth
Journal:  Ann Thorac Surg       Date:  1982-06       Impact factor: 4.330

8.  Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers.

Authors:  Y Shimosato; A Suzuki; T Hashimoto; Y Nishiwaki; T Kodama; T Yoneyama; T Kameya
Journal:  Am J Surg Pathol       Date:  1980-08       Impact factor: 6.394

9.  Increasing incidence of adenocarcinoma of the lung.

Authors:  J Valaitis; S Warren; D Gamble
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

10.  Survival rates of lung cancer according to histological type.

Authors:  O Campobasso; B Invernizzi; M Musso; F Berrino
Journal:  Br J Cancer       Date:  1974-03       Impact factor: 7.640

View more
  2 in total

1.  Sole expression of laminin gamma 2 chain in invading tumor cells and its association with stromal fibrosis in lung adenocarcinomas.

Authors:  Y Kagesato; H Mizushima; N Koshikawa; H Kitamura; H Hayashi; N Ogawa; M Tsukuda; K Miyazaki
Journal:  Jpn J Cancer Res       Date:  2001-02

2.  Reduced expression of laminin alpha 3 and alpha 5 chains in non-small cell lung cancers.

Authors:  T Akashi; E Ito; Y Eishi; M Koike; K Nakamura; R E Burgeson
Journal:  Jpn J Cancer Res       Date:  2001-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.